Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

Paclitaxel Liposome for Injection

Paclitaxel liposome for injection is a cytotoxic anti-tumor drug with the following indications:
This product is mainly used in the clinic for first-line chemotherapy of ovarian cancer and the treatment of ovarian metastatic cancer in the future. As first-line chemotherapy, this product can also be used in combination with cisplatin.
It can also be used for follow-up treatment of breast cancer patients who have used standard chemotherapy containing doxorubicin or for the treatment of recurrent patients.
It can be used in combination with cisplatin for first-line chemotherapy of patients with non-small cell lung cancer who cannot undergo surgery or radiotherapy.
The main component of paclitaxel liposome for injection is paclitaxel, which can promote the assembly of microtubule dimers and prevent their disassembly. It can also lead to abnormal arrangement of microtubules throughout the cell cycle and the production of microtubule astrocytes during cell division, thereby hindering cell division and inhibiting tumor growth.

Share:

Featured products

Laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.